Notice: This company has been marked as potentially delisted and may not be actively trading. iPath CBOE S&P 500 BuyWrite ETN (BWV) News Today Add Share Share Headlines Stock Analysis All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period CBOE S&P 500 BuyWrite (BXM) LiveAugust 30, 2024 | uk.investing.comCBOE S&P 500 9-Day Volatility IndexAugust 9, 2024 | wsj.comCBOE S&P 500 Buffer Protect Ind (^SPRO07)August 2, 2024 | finance.yahoo.comCboe S&P 500 BuyWrite UCITS Ind (^BXMU)April 17, 2024 | finance.yahoo.comiPath S&P 500 VIX Shrt-Trm Fut (DE) ETN (VXIS.L)April 16, 2024 | finance.yahoo.comBWV:CA iPath CBOE S&P 500 BuyWrite Index ETNApril 9, 2024 | seekingalpha.comiPath S&P 500 Dynamic VIX ETN (XVZ)April 5, 2024 | finance.yahoo.comS&P 500 Life Sciences Tools & Services Industry IndexFebruary 23, 2024 | wsj.comOnconetix™ Chief Executive Officer Dr. Neil J. Campbell Issues Letter to ShareholdersDecember 19, 2023 | finance.yahoo.comCBOE S&P 500 10% Buffered Zero Apr (SP0BF10A)November 2, 2023 | uk.investing.comBlue Water Biotech Signs Non-Binding Term Sheet to Acquire a Commercial Stage Oncology CompanyNovember 2, 2023 | finance.yahoo.comBlue Water Biotech Announces It Has Regained Compliance with Nasdaq Listing Rule 5250(c)(1)November 1, 2023 | finance.yahoo.comCBOE S&P 500 15% Buffer Protect February (SPRF02)October 31, 2023 | uk.investing.comBlue Water Biotech Issues Letter to ShareholdersOctober 30, 2023 | finance.yahoo.comCBOE S&P 500 15% Buffer Protect October (SPRF10)October 25, 2023 | uk.investing.comCBOE S&P 500 BuyWrite (BXM)October 24, 2023 | investing.comCBOE S&P 500 15% Buffer Protect May (SPRF05)October 24, 2023 | uk.investing.comCBOE S&P 500 10% Buffered Jan (SPBUF10J)October 21, 2023 | uk.investing.comCBOE S&P 500 15% Buffer Protect January (SPRF01)October 21, 2023 | uk.investing.comCBOE S&P 500 15% Buffer Protect Balanced (SPRF)October 17, 2023 | uk.investing.comCBOE S&P 500 Conditional BuyWrite (BXMC)October 13, 2023 | investing.comCBOE S&P 500 30-Delta BuyWrite (BXMD)October 12, 2023 | investing.comCBOE S&P Financials Select Sector Half BuyWrite (BXLFH)October 11, 2023 | uk.investing.comCBOE S&P 500 ESG BuyWrite (BXESG)October 11, 2023 | investing.comCBOE S&P 500 15% Buffer Protect August (SPRF08)October 10, 2023 | uk.investing.comBlue Water Biotech Appoints Dr. Neil J. Campbell as President and CEO and Bruce Harmon as CFOOctober 10, 2023 | finance.yahoo.comCBOE S&P 500 15% Buffer Protect April (SPRF04)October 9, 2023 | uk.investing.comCboe S&P 500 Half BuyWrite Inde (^BXMH)September 3, 2023 | finance.yahoo.comBlue Water Biotech, Inc. Announces Notification From Nasdaq Related to Delayed Quarterly Report on Form 10-QAugust 28, 2023 | finance.yahoo.comBlue Water Biotech and Copay Consultants Collaborate to Build Copay Assistance Programs for Blue Water’s Commercial ProductsAugust 10, 2023 | finance.yahoo.comBlue Water Biotech Announces Exercise of Warrants and Issuance of New Warrants in A Private Placement For $2.7 Million Gross ProceedsAugust 1, 2023 | finance.yahoo.comBlue Water Biotech and Knipper Health Join Forces to Distribute Samples for ENTADFI® and ZONTIVITY® to PhysiciansJuly 31, 2023 | finance.yahoo.comBlue Water Biotech Teams with UpScriptHealth to Launch Telemedicine Platform for Benign Prostatic Hyperplasia Asset, ENTADFI®July 25, 2023 | finance.yahoo.comCBOE S&P 500 30-Delta BuyWrite Technical AnalysisJuly 23, 2023 | investing.comVXZB - iPath Series B S&P 500 VIX Mid-Term Futures ETNJuly 23, 2023 | finance.yahoo.comBlue Water Biotech Issues CEO Shareholder Letter Providing Update on Commercial Launch ActivitiesJuly 17, 2023 | finance.yahoo.comBlue Water Biotech Teams with Advantage Point Solutions to Provide Healthcare Payer Coverage SupportJuly 11, 2023 | finance.yahoo.comMainStay S&P 500 Index IJuly 9, 2023 | morningstar.comBlue Water Biotech Teams with BFW Advertising to Market and Advertise Commercial Product PortfolioJuly 6, 2023 | finance.yahoo.comMonkeypox Vaccine: Blue Water Biotech Touts Encouraging Preclinical Data From Monkeypox Vaccine CandidateJune 28, 2023 | finance.yahoo.comWill Blue Water Biotech (NASDAQ:BWV) Spend Its Cash Wisely?June 15, 2023 | finance.yahoo.comBlue Water Biotech Expands Commercial Portfolio by Acquiring Six FDA-Approved Drugs Across Various Treatment AreasJune 14, 2023 | finance.yahoo.comCBOE S&P 500 Multi-Week BuyWrite (BXMW)May 17, 2023 | investing.comCBOE S&P 500 BuyWrite Technical AnalysisMay 17, 2023 | investing.comBlue Water Biotech to Present Corporate Overview and ENTADFI® Launch Plan at the JMP Securities Life Sciences Conference in New York, NYMay 10, 2023 | finance.yahoo.comPrincipal Large Cap S&P 500 Index InstMay 9, 2023 | morningstar.comCBOE S&P 500 30-Delta BuyWrite (^BXMD)May 5, 2023 | finance.yahoo.comE-Mini S&P 500 Future Dec 2023April 26, 2023 | marketwatch.comBlue Water Biotech to Participate in the American Urological Association Annual Meeting 2023 to Promote Benign Prostatic Hyperplasia Treatment ENTADFI®April 25, 2023 | finance.yahoo.comE-Mini S&P 500 Future Jun 2023April 24, 2023 | marketwatch.com Get iPath CBOE S&P 500 BuyWrite ETN News Delivered to You Automatically Sign up to receive the latest news and ratings for BWV and its competitors with MarketBeat's FREE daily newsletter. Email Address When it comes to NVDA… “acceleration cycles” are the key (Ad)Expert options trader Graham Lindman has been working on a new way to tap into Nvidia’s options… By simply isolating outsized “acceleration cycles” within Nvidia stock (most investors don’t even know it exists)... And thanks to many months and late nights working out the kinks of the systems… They have finally found a way to target these cycles on Nvidia over and over again. Use this link to see Nvidia Unchained right away! BWV Media Mentions By Week BWV Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. BWV News Sentiment▼0.000.48▲Average Medical News Sentiment BWV News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. BWV Articles This Week▼00▲BWV Articles Average Week Get iPath CBOE S&P 500 BuyWrite ETN News Delivered to You Automatically Sign up to receive the latest news and ratings for BWV and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSEARCA:BWV) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding iPath CBOE S&P 500 BuyWrite ETN Please log in to your account or sign up in order to add this asset to your watchlist. Share iPath CBOE S&P 500 BuyWrite ETN With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.